CD274 and adenocarcinoma in situ: Similarly, Zhang et al. showed that there was no significant difference in PD-L1 expression among patients with adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive adenocarcinoma and this finding is also in line with ours [35].